13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 2 managers

Reported value

$2.54M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$1.94M

Price effect on 2 books still in the name

Largest holder

$2.22M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC276.3K$2.22M−$1.74MCut−$1.57M
Leonteq Securities AG40K$320.8K−$205.4KCut−$126.8K

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.